LifeMD, Inc.
LFMDLifeMD, Inc. in brief
LifeMD, Inc. is a listed company in the Retail - Pharmacy industry, based in New York, New York, USA. Its market value was $112 M on 30 October 2026, which makes it the 18,319th largest listed company in the world and the 3,466th largest in the USA on this site. In the year to December 2025 it had sales of $194 M and a net profit of $14 M, about 7 cents of profit for every dollar of sales. It employs about 389 people and Justin Schreiber is its chief executive. Its largest business segments by sales in 2025 were Telehealth (100%) and Telehealth Subscription Revenue (58%). Its shares trade under the symbol LFMD (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About LifeMD, Inc.
LifeMD is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. We believe the traditional healthcare model requiring patients to visit a physician’s office, travel to a retail pharmacy, and return for follow-up appointments or prescription refills is complex, inefficient, and costly which can discourage individuals from seeking necessary medical care and medications. At the same time, the United States continues to experience shortages in primary care key specialty areas.
From the company's annual report filed with the US SEC: read the report
LifeMD, Inc. timeline
- 2012
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2018
- ✎Renamed Conversion Labs, Inc.Formerly Immudyne, Inc..
- 2021
- ✎Renamed LifeMD, Inc.Formerly Conversion Labs, Inc..
- 2025
- 💰Record revenue of $194 millionFY2025, the highest of the 8 years on record.
Events of LifeMD, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,306 (Jan 2022) · #4,614 (Dec 2022) · #3,844 (Jul 2023) · #2,914 (Jan 2024) · #1,824 (Mar 2026) · #3,192 (Aug 2026) · #3,377 (Oct 2026) · #3,469 (Oct 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 0.6×
- Price / book
- 6.1×
- Free cash flow yield
- 5.7%
- Net margin (TTM)
- -0.2%
- Operating margin
- -4.0%
- Return on equity
- -2.1%
- Liabilities / assets
- 71.2%
- Revenue growth
- +25.3%
- R&D / revenue
- 1.6%
- Revenue per employee
- $499 K
- Profit per employee
- $37 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $194M | +25.3% | $-8M | $14M | 7.4% |
| Dec 2024 | $155M | +1.5% | $-20M | $-21M | -13.8% |
| Dec 2023 | $153M | +28.2% | $-14M | $-21M | -13.5% |
| Dec 2022 | $119M | +28.2% | $-43M | $-46M | -38.3% |
| Dec 2021 | $93M | +149.1% | $-54M | $-61M | -65.6% |
| Dec 2020 | $37M | +199.0% | $-58M | $-59M | -157.3% |
| Dec 2019 | $12M | +49.9% | $-3M | $-3M | -25.2% |
| Dec 2018 | $8M | — | $-2M | $-1M | -14.9% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $8M | $2M | $6M | $0.25 | — |
| Dec 2024 | $18M | $1M | $16M | $-0.60 | — |
| Dec 2023 | $9M | $0M | $9M | — | — |
| Dec 2022 | $-23M | $0M | $-23M | — | — |
| Dec 2021 | $-33M | $0M | $-33M | — | — |
| Dec 2020 | $-12M | — | — | — | — |
| Dec 2019 | $0M | — | — | — | — |
| Dec 2018 | $-1M | — | — | — | — |
Quarterly results
Latest quarter to Sep 2026: revenue $45M (-6.5% on a year earlier), net income $-4M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 12, 202610-QQuarterly report · period to Sep 2026
- Nov 12, 20268-KCurrent reportMaterial agreement · Results of operations · New financial obligation · Unregistered share sale · Regulation FD disclosure
- Sep 15, 20268-KCurrent reportRegulation FD disclosure
- Aug 5, 202610-QQuarterly report · period to Jun 2026
- Aug 5, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Jun 22, 20268-KCurrent reportRegulation FD disclosure
- May 6, 202610-QQuarterly report · period to Mar 2026
- May 6, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Apr 30, 2026DEF 14AProxy statement
- Mar 18, 20268-KCurrent reportDirectors or officers changed · Other events
- Mar 10, 202610-KAnnual report · period to Dec 2025
- Mar 9, 20268-KCurrent reportResults of operations · Regulation FD disclosure
Official filings of LifeMD, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $194 M
- Operating income
- $-8 M
- Net income
- $14 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $64 M
- Total liabilities
- $45 M
- Total equity
- $18 M
As of December-2025
Top 94 institutional investors in LifeMD, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Federated Hermes, Inc. | 4,049,974 | +1,302,319 (+47.40%) | 8.38% | $12 M | Nov 12, 2026 |
| 2 | BlackRock, Inc. | 3,020,174 | -14,361 (-0.47%) | 6.25% | $9 M | Nov 13, 2026 |
| 3 | Vanguard Capital Management LLC | 1,718,423 | -16,333 (-0.94%) | 3.56% | $5 M | Nov 13, 2026 |
| 4 | State Street Corp | 1,288,348 | -30,436 (-2.31%) | 2.67% | $4 M | Nov 12, 2026 |
| 5 | Geode Capital Management, LLC | 1,066,623 | -1,075 (-0.10%) | 2.21% | $3 M | Nov 6, 2026 |
| 6 | Renaissance Technologies LLC | 990,725 | -88,800 (-8.23%) | 2.05% | $3 M | Nov 12, 2026 |
| 7 | Prescott Group Capital Management, L.L.C. | 897,224 | 0 (0.00%) | 1.86% | $3 M | Oct 30, 2026 |
| 8 | Marshall Wace, LLP | 809,138 | +251,664 (+45.14%) | 1.67% | $2 M | Nov 13, 2026 |
| 9 | Tudor Investment Corp Et Al | 452,659 | +178,516 (+65.12%) | 0.94% | $1 M | Nov 16, 2026 |
| 10 | Susquehanna International Group, LLP | 404,325 | -73,951 (-15.46%) | 0.84% | $1 M | Nov 16, 2026 |
| 11 | Morgan Stanley | 356,343 | -47,778 (-11.82%) | 0.74% | $1 M | Nov 13, 2026 |
| 12 | Northern Trust Corp | 354,331 | -2,978 (-0.83%) | 0.73% | $1 M | Nov 16, 2026 |
| 13 | Citadel Advisors LLC | 333,953 | +70,482 (+26.75%) | 0.69% | $1 M | Nov 16, 2026 |
| 14 | Vanguard Fiduciary Trust Co | 298,503 | +14,550 (+5.12%) | 0.62% | $1 M | Nov 13, 2026 |
| 15 | Vanguard Portfolio Management LLC | 281,885 | +8,881 (+3.25%) | 0.58% | $1 M | Nov 13, 2026 |
| 16 | Goldman Sachs Group Inc | 232,501 | +132,883 (+133.39%) | 0.48% | $1 M | Nov 16, 2026 |
| 17 | UBS Group AG | 219,905 | +10,262 (+4.89%) | 0.46% | $1 M | Nov 10, 2026 |
| 18 | Bank of New York Mellon Corp | 211,298 | -35,288 (-14.31%) | 0.44% | $1 M | Nov 5, 2026 |
| 19 | Millennium Management LLC | 203,699 | -197,925 (-49.28%) | 0.42% | $1 M | Nov 16, 2026 |
| 20 | Walleye Capital LLC | 189,766 | -134,132 (-41.41%) | 0.39% | $1 M | Nov 13, 2026 |
| 21 | Barry Investment Advisors, LLC | 171,894 | 0 (0.00%) | 0.36% | $0 M | Oct 14, 2026 |
| 22 | Divisadero Street Capital Management, LP | 135,826 | 0 (0.00%) | 0.28% | $0 M | Nov 16, 2026 |
| 23 | Charles Schwab Investment Management Inc | 113,353 | -30 (-0.03%) | 0.23% | $0 M | Nov 16, 2026 |
| 24 | Courier Capital LLC | 108,500 | -61,500 (-36.18%) | 0.22% | $0 M | Oct 19, 2026 |
| 25 | Nuveen, LLC | 106,917 | +334 (+0.31%) | 0.22% | $0 M | Nov 10, 2026 |
Show all 94: investors 26 to 94
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | MAI Capital Management | 100,000 | -1,627 (-1.60%) | 0.21% | $0 M | Nov 12, 2026 |
| 27 | Atom Investors LP | 69,897 | New | 0.14% | $0 M | Nov 16, 2026 |
| 28 | Alliancebernstein L.P. | 63,960 | 0 (0.00%) | 0.13% | $0 M | Nov 16, 2026 |
| 29 | CIBC World Market Inc. | 63,700 | +33,700 (+112.33%) | 0.13% | $0 M | Nov 10, 2026 |
| 30 | Bridgeway Capital Management, LLC | 60,700 | -15,500 (-20.34%) | 0.13% | $0 M | Nov 16, 2026 |
| 31 | State of Wyoming | 60,062 | -5,668 (-8.62%) | 0.12% | $0 M | Oct 28, 2026 |
| 32 | Quinn Opportunity Partners LLC | 60,000 | -29,995 (-33.33%) | 0.12% | $0 M | Nov 10, 2026 |
| 33 | Empowered Funds, LLC | 55,000 | New | 0.11% | $0 M | Nov 13, 2026 |
| 34 | Bank Of America Corp /de/ | 54,811 | -206,203 (-79.00%) | 0.11% | $0 M | Nov 16, 2026 |
| 35 | AQR Capital Management LLC | 54,794 | -564,712 (-91.16%) | 0.11% | $0 M | Nov 16, 2026 |
| 36 | IMC-Chicago, LLC | 50,234 | -31,842 (-38.80%) | 0.10% | $0 M | Nov 5, 2026 |
| 37 | Group One Trading LLC | 45,777 | New | 0.09% | $0 M | Nov 10, 2026 |
| 38 | Rhumbline Advisers | 45,398 | -1,295 (-2.77%) | 0.09% | $0 M | Nov 10, 2026 |
| 39 | Jpmorgan Chase & Co | 33,965 | -19,144 (-36.05%) | 0.07% | $0 M | Nov 12, 2026 |
| 40 | Simplex Trading, LLC | 32,670 | -33,762 (-50.82%) | 0.07% | $0 M | Nov 4, 2026 |
| 41 | Price T Rowe Associates Inc /MD/ | 30,531 | +1,952 (+6.83%) | 0.06% | $0 M | Nov 16, 2026 |
| 42 | Quantbot Technologies LP | 30,363 | +8,744 (+40.45%) | 0.06% | $0 M | Nov 12, 2026 |
| 43 | Deutsche Bank AG\ | 29,765 | -4,244 (-12.48%) | 0.06% | $0 M | Nov 6, 2026 |
| 44 | Cambridge Investment Research Advisors, Inc. | 25,500 | -25,500 (-50.00%) | 0.05% | $0 M | Nov 2, 2026 |
| 45 | LPL Financial LLC | 24,687 | +19 (+0.08%) | 0.05% | $0 M | Nov 6, 2026 |
| 46 | Dynamic Technology Lab Private Ltd | 24,258 | +8,388 (+52.85%) | 0.05% | $0 M | Nov 13, 2026 |
| 47 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 22,481 | +675 (+3.10%) | 0.05% | $0 M | Nov 16, 2026 |
| 48 | Invesco Ltd. | 21,714 | -414 (-1.87%) | 0.04% | $0 M | Nov 12, 2026 |
| 49 | Franklin Templeton Inc | 20,953 | -34,855 (-62.46%) | 0.04% | $0 M | Nov 12, 2026 |
| 50 | All Options USA, LLC | 19,968 | -17,198 (-46.27%) | 0.04% | $0 M | Nov 12, 2026 |
| 51 | Royce & Associates LP | 19,573 | -616,551 (-96.92%) | 0.04% | $0 M | Nov 9, 2026 |
| 52 | State of Alaska, Department of Revenue | 17,501 | -2,521 (-12.59%) | 0.04% | $0 M | Oct 15, 2026 |
| 53 | Accurate Wealth Management, LLC | 16,676 | New | 0.03% | $0 M | Oct 20, 2026 |
| 54 | Barclays PLC | 15,805 | +9,567 (+153.37%) | 0.03% | $0 M | Nov 6, 2026 |
| 55 | Corient Private Wealth LP | 15,167 | 0 (0.00%) | 0.03% | $0 M | Nov 16, 2026 |
| 56 | Vanguard Global Advisers, LLC | 14,479 | +235 (+1.65%) | 0.03% | $0 M | Nov 13, 2026 |
| 57 | Russell Investments Group, Ltd. | 14,242 | -300,528 (-95.48%) | 0.03% | $0 M | Nov 6, 2026 |
| 58 | Schonfeld Strategic Advisors LLC | 13,592 | New | 0.03% | $0 M | Nov 16, 2026 |
| 59 | Wealthspire Advisors, LLC | 12,000 | -49,664 (-80.54%) | 0.02% | $0 M | Nov 13, 2026 |
| 60 | Magnus Financial Group LLC | 12,000 | 0 (0.00%) | 0.02% | $0 M | Oct 21, 2026 |
| 61 | Wells Fargo & Company/mn | 11,415 | -25,593 (-69.16%) | 0.02% | $0 M | Nov 16, 2026 |
| 62 | New York State Common Retirement Fund | 11,400 | 0 (0.00%) | 0.02% | $0 M | Nov 17, 2026 |
| 63 | NFSG Corp | 11,400 | 0 (0.00%) | 0.02% | $0 M | Oct 15, 2026 |
| 64 | Police & Firemen's Retirement System of New Jersey | 11,032 | 0 (0.00%) | 0.02% | $0 M | Nov 9, 2026 |
| 65 | Jump Financial, LLC | 10,153 | -61,065 (-85.74%) | 0.02% | $0 M | Nov 13, 2026 |
| 66 | Chapin Davis, Inc. | 10,000 | New | 0.02% | $0 M | Oct 9, 2026 |
| 67 | Tower Research Capital LLC (TRC) | 9,943 | +4,847 (+95.11%) | 0.02% | $0 M | Nov 16, 2026 |
| 68 | BNP Paribas Financial Markets | 9,610 | +3,856 (+67.01%) | 0.02% | $0 M | Nov 12, 2026 |
| 69 | FMR LLC | 6,341 | -3,060 (-32.55%) | 0.01% | $0 M | Nov 10, 2026 |
| 70 | Ameritas Investment Partners, Inc. | 3,399 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 71 | Legal & General Group Plc | 3,352 | 0 (0.00%) | 0.01% | $0 M | Nov 16, 2026 |
| 72 | Jones Financial Companies Lllp | 3,128 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
| 73 | Royal Bank Of Canada | 2,093 | -746 (-26.28%) | 0.00% | $0 M | Nov 16, 2026 |
| 74 | Citigroup Inc | 2,015 | -16,730 (-89.25%) | 0.00% | $0 M | Nov 4, 2026 |
| 75 | Global Retirement Partners, LLC | 1,900 | 0 (0.00%) | 0.00% | $0 M | Nov 10, 2026 |
| 76 | Summit Securities Group LLC | 1,283 | New | 0.00% | $0 M | Nov 5, 2026 |
| 77 | Sterling Capital Management LLC | 1,188 | +861 (+263.30%) | 0.00% | $0 M | Oct 22, 2026 |
| 78 | GAMMA Investing LLC | 1,184 | +500 (+73.10%) | 0.00% | $0 M | Oct 8, 2026 |
| 79 | IAG Wealth Partners, LLC | 1,000 | 0 (0.00%) | 0.00% | $0 M | Nov 6, 2026 |
| 80 | SBI Securities Co., Ltd. | 975 | +1 (+0.10%) | 0.00% | $0 M | Oct 22, 2026 |
| 81 | California State Teachers Retirement System | 553 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 82 | Leonteq Securities AG | 514 | 0 (0.00%) | 0.00% | $0 M | Oct 29, 2026 |
| 83 | MassMutual Private Wealth & Trust, FSB | 430 | +337 (+362.37%) | 0.00% | $0 M | Oct 5, 2026 |
| 84 | Arax Advisory Partners | 359 | -3,968 (-91.70%) | 0.00% | $0 M | Nov 12, 2026 |
| 85 | Robinhood Markets, Inc. | 274 | — | 0.00% | $0 M | Nov 18, 2026 |
| 86 | Caitong International Asset Management Co., Ltd | 213 | -2,672 (-92.62%) | 0.00% | $0 M | Oct 29, 2026 |
| 87 | EverSource Wealth Advisors, LLC | 104 | -685 (-86.82%) | 0.00% | $0 M | Nov 4, 2026 |
| 88 | IFP Advisors, Inc | 100 | 0 (0.00%) | 0.00% | $0 M | Oct 16, 2026 |
| 89 | Centerpoint Advisors, LLC | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 5, 2026 |
| 90 | Meriwether Wealth & Planning, LLC | 60 | New | 0.00% | $0 M | Oct 13, 2026 |
| 91 | PNC Financial Services Group, Inc. | 47 | -400 (-89.49%) | 0.00% | $0 M | Nov 6, 2026 |
| 92 | Essential Partners LLC | 32 | -370 (-92.04%) | 0.00% | $0 M | Oct 14, 2026 |
| 93 | Osaic Holdings, Inc. | 5 | New | 0.00% | $0 M | Nov 12, 2026 |
| 94 | SJS Investment Consulting Inc. | 4 | -111 (-96.52%) | 0.00% | $0 M | Oct 26, 2026 |
Mutual funds holding LifeMD, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Federated Hermes MDT Small Cap Core FundFederated Hermes MDT Series | 1.58 M | $6 M | 3.3% | 0.25% | +240% | Jul 31, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 1.22 M | $5 M | 2.5% | <0.01% | +8.6% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 1.04 M | $4 M | 2.2% | <0.01% | +7.3% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 687,863 | $3 M | 1.4% | 0.03% | +116% | Jun 30, 2026 |
| 🇺🇸 Federated Hermes MDT Small Cap Growth FundFederated Hermes MDT Series | 796,877 | $3 M | 1.6% | 0.33% | +142% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Kensho New Economies Composite ETFSSGA Funds Management, Inc. | 529,988 | $2 M | 1.1% | 0.08% | +68% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 475,103 | $2 M | 0.98% | <0.01% | −4.1% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 437,857 | $2 M | 0.91% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Royce Small-Cap Opportunity FundRoyce & Associates, LP | 295,103 | $1 M | 0.61% | 0.09% | −52% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 284,395 | $1 M | 0.59% | <0.01% | +31% | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 227,637 | $1 M | 0.47% | <0.01% | −1.1% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 205,038 | $1 M | 0.42% | <0.01% | +6.1% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 135,043 | $1 M | 0.28% | 0.04% | +37% | Jun 30, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 86,955 | $0 M | 0.18% | <0.01% | +43% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 Value ETFBlackRock Fund Advisors | 82,221 | $0 M | 0.17% | <0.01% | −24% | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 93,096 | $0 M | 0.19% | <0.01% | +11% | Jul 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 73,455 | $0 M | 0.15% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 70,500 | $0 M | 0.15% | 0.20% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 64,000 | $0 M | 0.13% | <0.01% | +7.2% | May 31, 2026 |
| 🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors | 59,470 | $0 M | 0.12% | <0.01% | +2.3% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 56,925 | $0 M | 0.12% | 0.02% | +1.3% | May 31, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 54,609 | $0 M | 0.11% | <0.01% | +16% | Jul 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 43,866 | $0 M | 0.09% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC | 47,758 | $0 M | 0.10% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC | 45,331 | $0 M | 0.09% | 0.06% | new | Jul 31, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 38,330 | $0 M | 0.08% | <0.01% | +33% | Jun 30, 2026 |
| 🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC | 33,523 | $0 M | 0.07% | 0.09% | −14% | Jun 30, 2026 |
| 🇺🇸 JPMorgan Diversified Return U.S. Small Cap Equity ETFJ.P. Morgan Investment Management Inc. | 38,666 | $0 M | 0.08% | 0.02% | −2.8% | Jul 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 28,129 | $0 M | 0.06% | <0.01% | +32% | Jun 30, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 26,844 | $0 M | 0.06% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 27,500 | $0 M | 0.06% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 25,459 | $0 M | 0.05% | <0.01% | +3.1% | May 31, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 25,630 | $0 M | 0.05% | <0.01% | +60% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 21,590 | $0 M | 0.04% | <0.01% | +27% | Jun 30, 2026 |
| 🇺🇸 Franklin U.S. Small Cap Equity FundFRANKLIN TEMPLETON FUND ADVISER, LLC | 20,419 | $0 M | 0.04% | 0.06% | no change | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 19,914 | $0 M | 0.04% | <0.01% | −6.9% | Jun 30, 2026 |
| 🇺🇸 AVIP BlackRock Advantage Small Cap Growth PortfolioCONSTELLATION INVESTMENTS INC | 19,161 | $0 M | 0.04% | 0.06% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 22,372 | $0 M | 0.05% | <0.01% | +16% | Jul 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 18,519 | $0 M | 0.04% | <0.01% | −22% | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 20,209 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 16,333 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 19,197 | $0 M | 0.04% | <0.01% | +14% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 14,010 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Small Cap Value Index FundFidelity Management & Research Company LLC | 14,002 | $0 M | 0.03% | <0.01% | −4.3% | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 13,749 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 12,700 | $0 M | 0.03% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 14,815 | $0 M | 0.03% | <0.01% | −4.9% | Jul 31, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 10,237 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 2000 Value Index FundThe Vanguard Group, Inc. | 8,950 | $0 M | 0.02% | <0.01% | +12% | May 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 9,114 | $0 M | 0.02% | 0.02% | +25% | Jun 30, 2026 |
| 🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc. | 9,076 | $0 M | 0.02% | <0.01% | −4.5% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 8,850 | $0 M | 0.02% | <0.01% | +17% | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 8,644 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 7,304 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 7,027 | $0 M | 0.01% | <0.01% | +7.4% | Jul 31, 2026 |
| 🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION | 5,700 | $0 M | 0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 5,697 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 5,455 | $0 M | 0.01% | <0.01% | +37% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Value FundOLIVE STREET INVESTMENT ADVISERS LLC | 4,880 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 4,721 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 4,699 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 5,464 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 4,196 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 3,931 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 4,582 | $0 M | <0.01% | <0.01% | +1.0% | Jul 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 4,409 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap Equity FundRussell Investment Management, LLC | 4,210 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 3,399 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 3,071 | $0 M | <0.01% | <0.01% | +45% | Jun 30, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 3,050 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 3,031 | $0 M | <0.01% | <0.01% | +15% | Jun 30, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 2,948 | $0 M | <0.01% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 3,316 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 2,466 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 2,862 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 2,613 | $0 M | <0.01% | <0.01% | +27% | Jul 31, 2026 |
| 🇺🇸 1290 VT Small Cap Value PortfolioEquitable Investment Management Group, LLC | 2,005 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 1,872 | $0 M | <0.01% | <0.01% | +10% | May 31, 2026 |
| 🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC | 1,463 | $0 M | <0.01% | <0.01% | −40% | May 31, 2026 |
| 🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC | 1,475 | $0 M | <0.01% | <0.01% | −39% | May 31, 2026 |
| 🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC | 1,411 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC | 1,245 | $0 M | <0.01% | <0.01% | −5.3% | May 31, 2026 |
| 🇺🇸 PD Small-Cap Value Index PortfolioPacific Life Fund Advisors LLC | 1,285 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 VIP Total Market Index PortfolioFidelity Management & Research Company LLC | 1,204 | $0 M | <0.01% | <0.01% | +48% | Jun 30, 2026 |
| 🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc. | 944 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC | 841 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC | 829 | $0 M | <0.01% | <0.01% | −8.3% | Jun 30, 2026 |
| 🇺🇸 TIAA Separate Account VA-1 - Stock Index AccountTeachers Advisors, LLC | 796 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Small-Cap Equity PortfolioPacific Life Fund Advisors LLC | 617 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Nuveen Life Stock Index FundTeachers Advisors, LLC | 529 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street Balanced Index FundSSGA Funds Management, Inc. | 320 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 SmallCap Value Fund IIPrincipal Global Investors, LLC | 268 | $0 M | <0.01% | <0.01% | −35% | Jul 31, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 225 | $0 M | <0.01% | <0.01% | +13% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 93 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at LifeMD, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Joan LarovereDirector | Grant or award | +35,000 | — | — | 142,050 | Form 4 |
| filed | John R. Strawn Jr.Director | Grant or award | +35,000 | — | — | 498,001 | Form 4 |
| filed | Calum Archibald MacraeDirector | Grant or award | +35,000 | — | — | 73,865 | Form 4 |
| filed | Joseph DiTrolioDirector | Grant or award | +35,000 | — | — | 308,413 | Form 4 |
| filed | Roberto SimonDirector | Grant or award | +35,000 | — | — | 288,175 | Form 4 |
| filed | Umesh SripadChief Technology Officer | Grant or award | +75,000 | — | — | 75,000 | Form 4 |
| filed | Atul KavthekarChief Financial Officer | Grant or award | +337,500 | — | — | 337,500 | Form 4 |
| filed | John R. Strawn Jr.Director | Grant or award | +50,000 | — | — | 463,001 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: LifeMD, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2025 | Q3 2025 | $0.3M |
Fails to deliver
- : 7,759 shares at $2.32
- : 10,728 shares at $2.12
- : 4,827 shares at $2.17
- : 353 shares at $2.14
- : 51,002 shares at $2.34
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
LifeMD, Inc. scorecard#
Passes 18 of the 26 checks that could be worked out: strongest in growth (6 of 6), weakest in valuation (3 of 6). Fiscal year 2025; market cap of Oct 30, 2026.
Valuation3 of 6
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' median6.1×Price to book 6.1× against Healthcare's median of 3.1×.
- ✓Price to sales below its peers' median0.6×Price to sales 0.6× against Healthcare's median of 3.8×.
- ✓Free cash flow yield above 5%5.7%Free cash flow is 5.7% of the market value.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- ✓The price assumes slower growth than the last three years'-0.5%The price assumes -0.5% a year for ten years; revenue grew 17.7% a year over the last three.
Growth6 of 6
- ✓Revenue grew in the newest year25.4%Revenue up 25.4% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years17.7%17.7% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median17.7%17.7% a year against Retail - Pharmacy's median of 0.4% (6 companies).
- ✓Earnings per share grew in the newest year0.25 vs -0.60Diluted EPS 0.25 in fiscal 2025 against -0.60 the year before (report's currency).
- ✓Net income higher than five years earlier$14 M$14 M in fiscal 2025 against -$59 M in 2020.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
Profitability3 of 5
- ✓Profitable in the newest year$14 MNet income $14 M in fiscal 2025.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-4.0%-4.0% against Retail - Pharmacy's median of -2.4% (7 companies).
- ✓Return on equity above 15%310.3%310.3% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-4.0%-4.0% in fiscal 2025 against -36.5% in 2022.
Financial health2 of 4
- ✓Short-term assets cover short-term liabilities1.1×Current ratio 1.14 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-5.6×Operating income -5.6 times interest in fiscal 2025.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-0.90Z-score -0.90 (distress zone) for fiscal 2025.
Shareholder returns4 of 5
- ✓Pays a dividendYesPaid dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- ✓Dividends under 75% of net income21.7%Dividends were 21.7% of net income in fiscal 2025.
- ✗Share count up no more than 2% in a year9.6%Diluted shares up 9.6% in fiscal 2025.
- ✓Dividends and buybacks above 3% of the market value3.0%Dividends and buybacks were 3.0% of the market value.
- ✓Free cash flow covers dividends and buybacks$6 MFree cash flow $6 M against $3 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Retail - Pharmacy, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from LifeMD, Inc.'s statements, beside the median of Retail - Pharmacy.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -4.0% | -2.4% | |
| Net margin | 7.4% | -1.4% | |
| Return on equity | 310.3% | -49.7% | |
| Revenue growth, 3 years a year | 17.7% | 0.4% | |
| Revenue growth | 25.4% | 8.3% | |
| Free cash flow margin | 3.3% | -0.3% |
5of 8on the Piotroski tests of financial strength
- The share count rose 9.6% in the year.
- Operating income covers the interest bill only -5.6 times.
- Revenue has grown 8 years in a row.
LifeMD, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 | FY 2016to Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 194+25.3%100% | 155r212+1.5%100% | 153+28.2%100% | 119+28.2%100% | 93+149%100% | 37+199%100% | 12+49.8%100% | 8.3+126%100% | 3.7r5.1−29.7%100% | 5.2—100% | |
| Cost of revenue | 28+29.3%14.3% | 21r24+13.4%13.8% | 19+1.2%12.4% | 19+3.7%15.7% | 18+103%19.4% | 8.9r8.9+251%23.8% | 2.5r3.3+26.5%20.3% | 2.0r2.0+96.1%24.0% | 1.0r1.5−47.7%27.6% | 1.9—37.1% | |
| Gross profit | 166+24.7%85.7% | 133r188−0.2%86.2% | 134+33.2%87.6% | 100+34.0%84.3% | 75+163%80.6% | 28r28+186%76.2% | 9.9r9.2+57.1%79.7% | 6.3r6.4+138%76.0% | 2.7r3.6−19.1%72.4% | 3.3—62.9% | |
| Selling and marketing | 86+22.8%44.4% | 70r103−8.3%45.3% | 76−2.4%50.1% | 78−5.1%65.8% | 83+111%88.9% | 39r42+338%105% | 8.9r8.2+75.5%71.5% | 5.1—61.0% | — | — | |
| General and administrative | 58−0.0%29.9% | 58r73+12.1%37.4% | 52+10.1%33.9% | 47+18.8%39.5% | 40r40−12.1%42.6% | 45r42+1774%121% | 2.4+4.8%19.2% | 2.3r1.1+208%27.5% | 0.7r0.9−28.1%20.2% | 1.0—19.7% | |
| Operating expenses | 174+13.2%89.7% | 154r205+3.8%99.3% | 148+3.0%97.1% | 144+11.3%121% | 129+49.8%139% | 86r86+572%231% | 13r12+53.1%103% | 8.4r8.4+115%101% | 3.9r4.6−12.9%106% | 4.5—85.3% | |
| Operating income | −7.7—−4.0% | −20r−16—−13.2% | −14—−9.5% | −43—−36.5% | −54—−58.5% | −58—−155% | −2.9—−23.2% | −2.1—−24.7% | −1.2r−1.1—−33.4% | −1.2—−22.4% | |
| Interest expense and finance costs | 1.4−37.4%0.7% | 2.2r2.2−16.2%1.4% | 2.6+104%1.7% | 1.3−57.7%1.1% | 3.0+81.1%3.3% | 1.7+119%4.5% | 0.8+115%6.1% | 0.4+253%4.3% | 0.1+107%2.7% | 0.0—0.9% | |
| Other non-operating income (expense) | — | — | — | — | — | −2.6—−6.9% | −0.8—−6.1% | — | −1.2—−33.1% | −1.2—−23.4% | |
| Income before tax | −10—−5.2% | −23r−18—−14.6% | −17—−11.4% | −45—−37.5% | −61—−66.0% | −60—−162% | −3.7—−29.3% | −2.4r−1.5—−29.0% | −1.4—−37.5% | −1.2—−23.4% | |
| Income tax | 0.0−92.4%0.0% | 0.6r0.4+39.7%0.4% | 0.4+18.7%0.3% | 0.4+4584%0.3% | 0.0−93.7%0.0% | 0.1—0.3% | −0.1—−1.0% | −0.1—−1.5% | — | — | |
| Income from continuing operations | −10—−5.3% | −23—−15.0% | — | — | — | — | — | — | — | — | |
| Income from discontinued operations | 26+1017%13.3% | 2.3—1.5% | — | — | — | — | — | 0.9r0.9+476%11.1% | 0.2—4.4% | — | |
| Net income including minority interests | 16—8.0% | −21r−19—−13.5% | −18—−11.7% | −45—−37.8% | −61—−66.0% | −61—−162% | −3.5—−28.3% | −1.4r−1.4—−16.3% | −1.2—−33.1% | −1.2—−23.4% | |
| Minority interests' share of net income | 1.3+131%0.7% | 0.5r0.2−80.1%0.4% | 2.8+436%1.8% | 0.5—0.4% | −0.4—−0.5% | −1.9—−5.0% | −0.4—−3.1% | −0.1—−1.4% | −0.0—−0.3% | −0.1—−2.2% | |
| Net income attributable to shareholders | 14—7.4% | −21r−19—−13.8% | −21—−13.5% | −46—−38.3% | −61—−65.6% | −59—−157% | −3.1—−25.2% | −1.2r−1.2—−14.9% | −1.2—−32.8% | −1.1—−21.1% | |
| Earnings per share, basic | 0.25—— | -0.60—— | — | — | — | — | — | — | -0.03—— | -0.03—— | |
| Earnings per share, diluted | 0.25—— | -0.60—— | — | — | — | — | — | — | -0.03—— | -0.03—— | |
| Shares, weighted average (basic) | 45+9.5%— | 41+21.5%— | 34+9.5%— | 31+14.7%— | 27+89.2%— | 14+44.2%— | 9.9r49−77.6%— | 44+5.9%— | 42+24.7%— | 33—— | |
| Shares, weighted average (diluted) | 45+9.5%— | 41+21.5%— | 34+9.5%— | 31+14.7%— | 27+89.2%— | 14+44.2%— | 9.9r49−77.6%— | 44+5.9%— | 42+24.7%— | 33—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 37+5.1%57.8% | 35+5.6%46.0% | 33+737%56.7% | 4.0−90.4%15.4% | 41+350%82.8% | 9.2+729%68.5% | 1.1+514%32.1% | 0.2+27.4%6.9% | 0.1−22.6%11.2% | 0.2—23.1% | |
| Receivables | 2.5r9.3−76.2%3.9% | 10r8.2+66.9%13.7% | 6.3r5.3+121%10.7% | 2.8+189%11.0% | 1.0−1.8%2.0% | 1.0r0.6+924%7.4% | 0.1−1.6%2.8% | 0.1−22.7%3.8% | 0.1r0.4−71.2%10.1% | 0.4—56.3% | |
| Inventory | 2.8−0.9%4.4% | 2.8+1.4%3.7% | 2.8−25.5%4.7% | 3.7+129%14.4% | 1.6+27.9%3.2% | 1.3+33.1%9.4% | 1.0−7.1%27.6% | 1.0+50.1%39.1% | 0.7r0.7+325%53.9% | 0.2—20.3% | |
| Other current assets | 2.6−11.9%4.2% | 3.0r2.7+221%3.9% | 0.9+36.0%1.6% | 0.7−13.4%2.7% | 0.8+412%1.6% | 0.2−65.0%1.2% | 0.4+64.1%12.9% | 0.3—10.3% | — | — | |
| Current assets | 45r52−14.0%70.8% | 52r49+22.9%68.8% | 43+277%72.9% | 11−74.8%44.1% | 45+262%90.0% | 12r12+352%92.6% | 2.7+71.2%79.7% | 1.6+27.0%61.4% | 1.3+60.0%100% | 0.8—100% | |
| Property, plant and equipment | 2.4+69.8%3.8% | 1.4r1.5+202%1.9% | 0.5−0.0%0.8% | 0.5+104%1.9% | 0.2—0.5% | — | — | — | — | — | |
| Right-of-use (leased) assets | 5.3−15.4%8.3% | 6.2r6.4+947%8.2% | 0.6−50.7%1.0% | 1.2−31.2%4.7% | 1.8+539%3.5% | 0.3+1062%2.0% | 0.0—0.7% | — | — | — | |
| Goodwill | — | — | — | 8.0r0—31.2% | 0—0.0% | — | — | — | — | — | |
| Other intangible assets | 0.3+392%0.4% | 0.1r2.0−98.2%0.1% | 3.0−21.5%5.1% | 3.8+19291%14.9% | 0.0−94.2%0.0% | 0.3−49.7%2.5% | 0.7−33.2%19.6% | 1.0—38.6% | — | — | |
| Non-current assets | 19−21.7%29.2% | 24+49.4%31.2% | 16+10.6%27.1% | 14+187%55.9% | 5.0+405%10.0% | 1.0+41.7%7.4% | 0.7−30.9%20.3% | 1.0—38.6% | — | — | |
| Total assets | 64r70−16.4%100% | 76r72+30.1%100% | 58+128%100% | 26−48.6%100% | 50+272%100% | 13r13+289%100% | 3.4+31.7%100% | 2.6+107%100% | 1.3+60.0%100% | 0.8—100% | |
| Accounts payable | 14+29.8%22.2% | 11r16−1.6%14.3% | 11+9.7%19.0% | 10+11.6%39.4% | 9.1−13.0%18.1% | 10r12+241%77.7% | 3.1+251%88.5% | 0.9+106%33.2% | 0.4r0.5−43.9%33.4% | 0.8—95.3% | |
| Current liabilities | 40r42−41.3%62.2% | 67r60+93.8%88.6% | 35+10.9%59.5% | 31+37.5%122% | 23+63.8%45.7% | 14r13+250%104% | 4.0+233%115% | 1.2+86.0%45.6% | 0.6−44.3%50.7% | 1.2—146% | |
| Lease liabilities (non-current) | 5.7−9.5%8.9% | 6.3r6.3+8402%8.3% | 0.1−87.1%0.1% | 0.6−51.3%2.2% | 1.2+513%2.4% | 0.2—1.4% | — | — | — | — | |
| Total liabilities | 45r47−45.9%71.2% | 84r77+58.1%110% | 53+60.5%90.5% | 33+36.8%128% | 24+69.5%48.3% | 14r14+211%106% | 4.6+155%133% | 1.8+180%68.7% | 0.6—50.7% | — | |
| Retained earnings | −233r−229—−367% | −240r−236—−315% | −214—−366% | −191—−742% | −142—−284% | −80—−598% | −17—−482% | −12—−464% | −11—−862% | −9.7—−1227% | |
| Shareholders' equity | 18r23—28.8% | −9.1r−5.5−359%−11.9% | 3.5—6.0% | −11−150%−44.4% | 23—45.5% | −2.3—−17.2% | −1.0−210%−28.7% | 0.9+1.8%34.3% | 0.9—69.8% | −0.4—−45.0% | |
| Minority interests | — | 1.5r1.4−25.8%2.0% | 2.1—3.5% | −0.5—−1.9% | −1.0—−2.1% | −2.2—−16.2% | −0.1—−4.1% | −0.1—−3.0% | −0.3—−20.5% | −0.0—−0.8% | |
| Total equity | 18r23—28.8% | −11r−4.0−360%−14.3% | 4.2r5.6—7.2% | −12−155%−46.3% | 22—43.5% | −4.5—−33.4% | −1.1r−1.1−238%−32.8% | 0.8+31.6%31.3% | 0.6—49.3% | −0.4—−45.8% | |
| Total liabilities and equity | 64r70−16.4%100% | 76r72+30.1%100% | 58+128%100% | 26−48.6%100% | 50+272%100% | 13r13+289%100% | 3.4+31.7%100% | 2.6+107%100% | 1.3+60.0%100% | 0.8—100% | |
| Shares outstanding | 47+10.6%— | 42+10.3%— | 38+21.6%— | 31+2.8%— | 31+31.2%— | 23+121%— | 11r53−76.6%— | 45+2.9%— | 44+24.8%— | 35—— | |
| Cash-flow statement | |||||||||||
| Share-based compensation | 10−14.2%5.4% | 12−2.0%7.9% | 12−9.1%8.2% | 14+13.8%11.5% | 12−35.3%13.0% | 19+2444%50.0% | 0.7+168%5.9% | 0.3+68.1%3.3% | 0.2−72.3%4.4% | 0.6—11.2% | |
| Cash from operating activities | 8.3−52.7%4.3% | 18+98.6%11.3% | 8.8—5.8% | −23—−19.3% | −33—−35.6% | −12−4925%−32.5% | 0.3—2.0% | −0.9r−0.9—−10.9% | −0.8—−22.2% | −0.4—−7.8% | |
| Capital expenditure | −1.9—−1.0% | −1.5r−1.5—−0.9% | −0.2—−0.1% | −0.4—−0.3% | −0.2—−0.3% | — | — | — | — | — | |
| Intangible assets bought | — | −0.0—−0.0% | −0.1—−0.1% | −4.0—−3.4% | −0.0—−0.0% | — | — | −0.1—−1.2% | — | — | |
| Acquisitions, net of cash acquired | — | — | — | −1.0—−0.9% | — | — | — | −0.1—−1.8% | — | — | |
| Cash from investing activities | 6.9—3.6% | −12—−7.5% | −8.7—−5.7% | −14—−11.7% | −3.4—−3.7% | −0.8—−2.1% | −0.1−171%−0.8% | 0.1—1.7% | — | — | |
| Debt issued | — | — | — | — | 15—16.2% | — | — | — | — | — | |
| Debt repaid | −19—−9.6% | — | — | — | −15—−16.2% | — | −0.3—−2.3% | — | — | — | |
| Shares issued | 8.7—4.5% | — | 10—6.6% | — | 0.5−78.9%0.5% | 2.3+568%6.3% | 0.3—2.8% | — | 0.7r−0.1—18.3% | −0.1—−1.7% | |
| Shares bought back | −0.3—−0.1% | — | — | — | — | — | — | — | −0.1—−2.1% | — | |
| Dividends paid | −3.1—−1.6% | −3.1—−2.0% | −3.1—−2.0% | −3.1—−2.6% | −0.9—−0.9% | — | — | — | — | — | |
| Cash from financing activities | −13—−6.9% | −4.1−114%−2.7% | 29—19.1% | −0.5−101%−0.4% | 69+227%73.9% | 21+2610%56.3% | 0.8−3.4%6.2% | 0.8+3.4%9.6% | 0.8+117%21.1% | 0.4—6.8% | |
| Change in cash | 1.8−4.1%0.9% | 1.9−93.6%1.2% | 29—19.1% | −37−216%−31.4% | 32+298%34.6% | 8.1+771%21.6% | 0.9+2293%7.4% | 0.0—0.5% | −0.0—−1.1% | −0.1—−1.0% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q4 FY2023to Dec 31, 2023 | Q3 FY2023to Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 189+23.6%100% | 45−6.5%100% | 47−3.5%100% | 50−1.4%100% | 47r7.1*+760%100% | 48r60−10.4%100% | 49r62−3.2%100% | 51r66—100% | 5.5r64*−87.8%100% | 53r53+38.0%100% | 51—100% | 45*—100% | 39—100% | |
| Cost of revenue | 26−11.4%13.5% | 8.2+16.8%18.5% | 5.3−22.7%11.2% | 5.9−27.2%11.8% | 6.1r4.2*−10.5%12.9% | 7.1r7.4+40.9%14.8% | 6.8r7.4+36.1%14.0% | 8.1r8.6—16.0% | 6.8r9.4*+27.0%124% | 5.0+4.9%9.4% | 5.0—9.9% | 5.4*—11.9% | 4.8—12.4% | |
| Gross profit | 164+31.7%86.5% | 36−10.6%81.5% | 42−0.4%88.8% | 44+3.5%88.2% | 41r2.8*—87.1% | 41r53−15.7%85.2% | 42r55−7.6%86.0% | 43r57—84.0% | −1.3r55*−103%−24.0% | 48r48+42.6%90.6% | 46—90.1% | 40*—88.1% | 34—87.6% | |
| Selling and marketing | 95—50.5% | 19−18.0%41.5% | 28+26.6%59.3% | 30+34.1%59.6% | 19*—40.4% | 23r29−15.2%47.3% | 22r29−16.0%45.2% | 22r29—43.8% | — | 27+34.6%50.0% | 26—52.1% | 20*—45.5% | 20—51.2% | |
| General and administrative | 58+18.3%30.9% | 15+6.2%32.8% | 14−5.5%28.9% | 15+5.8%30.3% | 15r6.7*+120%31.7% | 14r17−23.8%28.9% | 14r18−22.0%29.5% | 14r17—28.2% | 6.8r20*−56.4%124% | 18r19+35.2%34.0% | 19—36.6% | 16*—34.7% | 13—34.7% | |
| Operating expenses | 184+34.7%97.5% | 41−6.7%91.5% | 49+10.3%104% | 53+21.0%106% | 41r9.1*+788%87.6% | 44r55−16.2%91.8% | 45r56−14.3%90.8% | 44r55—86.3% | 4.7r54*−88.8%84.8% | 52r53+36.1%98.1% | 52—103% | 42*—92.9% | 38—99.5% | |
| Operating income | −21—−11.0% | −4.5—−10.0% | −7.1—−15.1% | −8.9—−17.8% | −0.2r−6.2*—−0.5% | −3.1r−2.0—−6.6% | −2.3r−0.9—−4.8% | −1.2r2.5—−2.3% | −6.0r1.0*—−109% | −4.0r−4.7—−7.5% | −6.3—−12.4% | −2.2*—−4.8% | −4.6—−11.8% | |
| Interest expense and finance costs | — | 0.0−98.8%0.0% | −0.0−107%−0.1% | −0.1−112%−0.1% | — | 0.3r0.3−53.3%0.5% | 0.7r0.7+24.3%1.3% | 0.5r0.6—0.9% | 0.6r0.6*−2.4%11.1% | 0.6−21.7%1.0% | 0.5—1.0% | 0.6*—1.4% | 0.7—1.8% | |
| Income before tax | −21—−10.9% | −4.5—−10.0% | −7.1—−15.0% | −8.9—−17.7% | −0.2r−6.0*—−0.4% | −4.5r−3.4—−9.5% | −3.0—−6.1% | −1.6—−3.2% | −6.6r0.4*—−120% | −4.6r−5.2—−8.6% | — | −2.8*—−6.2% | −5.3—−13.7% | |
| Income tax | — | — | — | — | 0.0r−0.1*−96.2%0.0% | 0.0r0.2−86.3%0.1% | — | — | 0.4r0.2*—6.7% | 0.2—0.4% | — | — | — | |
| Income from continuing operations | −21—−10.9% | −4.5—−10.0% | −7.1—−15.0% | −8.9—−17.7% | −0.2*—−0.5% | −4.6—−9.6% | −3.0—−6.1% | −1.6—−3.2% | — | — | — | — | — | |
| Income from discontinued operations | — | — | — | — | 21*—44.6% | 0.9—2.0% | 1.9—3.9% | 2.0—3.9% | — | — | — | — | — | |
| Net income including minority interests | 0.2—0.1% | −4.5—−10.0% | −7.6r−7.1—−16.1% | −8.5r−8.9−1452%−16.9% | 21r20*—44.1% | −3.6r−3.6—−7.6% | −2.2r−1.6—−4.4% | 0.6r1.9—1.2% | −4.6r0.2*—−84.3% | −4.8r−5.5—−9.0% | −7.5r−6.8—−14.9% | −3.2*—−7.2% | −5.3—−13.7% | |
| Minority interests' share of net income | — | — | — | — | −0.0*−107%−0.0% | 0.2—0.5% | 0.5+1208%1.0% | 0.5—1.0% | 0.3r0.3*−38.8%5.7% | −0.1r−0.3−115%−0.2% | 0.0—0.1% | 0.5*—1.1% | 0.8—2.2% | |
| Net income attributable to shareholders | 0.4—0.2% | −4.5—−10.0% | −7.1—−15.0% | −8.9—−17.7% | 21r20*—44.1% | −3.9r−3.8—−8.1% | −1.6r−2.1—−3.3% | −0.2r1.4—−0.4% | −4.9r−0.1*—−90.0% | −4.7r−5.1—−8.7% | −6.9—−13.6% | −3.7*—−8.3% | −6.1—−15.9% | |
| Earnings per share, basic | — | -0.11—— | -0.16—— | -0.20—— | — | -0.10—— | -0.05—— | -0.02—— | — | -0.13—— | — | — | — | |
| Earnings per share, diluted | — | -0.11—— | -0.16—— | -0.20—— | — | -0.10—— | -0.05—— | -0.02—— | — | -0.13—— | — | — | — | |
| Shares, weighted average (basic) | 48+4.4%— | 48+4.4%— | 48+7.6%— | 47+9.7%— | — | 46+9.9%— | 44+7.5%— | 43—— | — | 42+21.9%— | 41—— | — | 34—— | |
| Shares, weighted average (diluted) | 48+4.4%— | 48+4.4%— | 48+7.6%— | 47+9.7%— | — | 46+9.9%— | 44+7.5%— | 43r46—— | — | 42+21.9%— | 41—— | — | 34—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 22—33.1% | 22−7.8%33.1% | 25−30.6%42.0% | 34+0.2%49.2% | 37+5.1%57.8% | 24−36.7%36.0% | 36+1.5%49.2% | 34—46.7% | 35+5.6%46.0% | 38+146%51.8% | 36—55.9% | 33—56.7% | 15—37.6% | |
| Receivables | 13—20.0% | 13+43.3%20.0% | 11+53.6%18.8% | 9.9−3.3%14.1% | 2.5r9.3−76.2%3.9% | 9.2+52.8%14.0% | 7.3+29.3%10.0% | 10—13.8% | 10r8.2+66.9%13.7% | 6.0+36.9%8.3% | 5.7—8.9% | 6.3r5.3—10.7% | 4.4—10.9% | |
| Inventory | 10—15.6% | 10+201%15.6% | 3.0−9.1%4.9% | 3.2+7.1%4.5% | 2.8−0.9%4.4% | 3.4+29.7%5.2% | 3.3+57.8%4.4% | 3.0—4.0% | 2.8+1.4%3.7% | 2.6−30.2%3.6% | 2.1—3.2% | 2.8—4.7% | 3.8—9.3% | |
| Other current assets | 3.5—5.3% | 3.5−17.2%5.3% | 2.5+26.6%4.2% | 3.9+73.1%5.5% | 2.6−11.9%4.2% | 4.3+90.0%6.4% | 2.0+29.2%2.7% | 2.2—3.0% | 3.0r2.7+221%3.9% | 2.2+71.6%3.1% | 1.5—2.4% | 0.9—1.6% | 1.3—3.2% | |
| Current assets | 49—74.3% | 49+19.9%74.3% | 42−14.2%70.3% | 52+3.5%73.7% | 45r52−14.0%70.8% | 41−15.6%62.3% | 49+8.8%66.6% | 50—67.9% | 52r49+22.9%68.8% | 49+95.5%67.1% | 45—70.6% | 43—72.9% | 25—61.2% | |
| Property, plant and equipment | 1.9—2.9% | 1.9−26.3%2.9% | 2.0−0.7%3.4% | 2.3+57.1%3.2% | 2.4+69.8%3.8% | 2.6+82.0%3.9% | 2.1+82.5%2.8% | 1.4—2.0% | 1.4r1.5+202%1.9% | 1.4+234%2.0% | 1.1—1.8% | 0.5—0.8% | 0.4—1.0% | |
| Right-of-use (leased) assets | 4.6—7.0% | 4.6−17.1%7.0% | 4.8−16.9%8.1% | 5.1−17.2%7.2% | 5.3−15.4%8.3% | 5.6−17.4%8.5% | 5.8+130%7.9% | 6.1—8.3% | 6.2r6.4+947%8.2% | 6.8+745%9.3% | 2.5—4.0% | 0.6—1.0% | 0.8—2.0% | |
| Goodwill | — | — | — | — | — | — | — | — | — | — | — | — | 8.0—19.7% | |
| Other intangible assets | 0.2—0.3% | 0.2−89.3%0.3% | 0.2−89.1%0.3% | 0.2−87.1%0.3% | 0.3+392%0.4% | 1.6−31.5%2.4% | 1.8−27.4%2.5% | 1.8—2.4% | 0.1r2.0−98.2%0.1% | 2.3−30.1%3.1% | 2.5—3.9% | 3.0—5.1% | 3.3—8.0% | |
| Non-current assets | 17—25.7% | 17−31.6%25.7% | 18−27.4%29.7% | 18−22.1%26.3% | 19−21.7%29.2% | 25+4.2%37.7% | 25+30.9%33.4% | 24—32.1% | 24+49.4%31.2% | 24+51.2%32.9% | 19—29.4% | 16—27.1% | 16—38.8% | |
| Total assets | 66—100% | 66+0.5%100% | 60−18.6%100% | 70−4.7%100% | 64r70−16.4%100% | 66−9.1%100% | 74+15.3%100% | 74—100% | 76r72+30.1%100% | 73+78.3%100% | 64—100% | 58—100% | 41—100% | |
| Accounts payable | 38—56.9% | 38+93.0%56.9% | 18−25.3%30.3% | 22+38.1%30.9% | 14+29.8%22.2% | 20+23.2%29.6% | 24+61.4%33.0% | 16—21.3% | 11r16−1.6%14.3% | 16+64.6%21.9% | 15—23.6% | 11—19.0% | 9.6—23.7% | |
| Current liabilities | 62—93.1% | 62+8.9%93.1% | 47−26.6%77.8% | 50−18.6%70.7% | 40r42−41.3%62.2% | 57−3.9%85.9% | 64+23.0%86.4% | 61—82.7% | 67r60+93.8%88.6% | 59+81.3%81.2% | 52—80.9% | 35—59.5% | 33—79.9% | |
| Lease liabilities (non-current) | 5.2—7.8% | 5.2−11.8%7.8% | 5.3−11.9%8.9% | 5.5−11.1%7.8% | 5.7−9.5%8.9% | 5.9−10.1%8.9% | 6.0+158%8.2% | 6.2—8.4% | 6.3r6.3+8402%8.3% | 6.5+3734%9.0% | 2.3—3.7% | 0.1—0.1% | 0.2—0.4% | |
| Total liabilities | 67—101% | 67+6.8%101% | 52−29.0%86.7% | 55−25.6%78.6% | 45r47−45.9%71.2% | 63−20.3%94.9% | 73+11.1%99.5% | 74—101% | 84r77+58.1%110% | 79+51.6%108% | 66—103% | 53—90.5% | 52—127% | |
| Retained earnings | −256—−387% | −256—−387% | −246—−411% | −238—−340% | −233r−229—−367% | −248—−376% | −238—−324% | −236—−320% | −240r−236—−315% | −235—−324% | −229—−360% | −214—−366% | −210—−515% | |
| Shareholders' equity | −0.6—−0.9% | −0.6−144%−0.9% | 8.0—13.3% | 15—21.4% | 18r23—28.8% | 1.3—2.0% | −1.8—−2.4% | −2.3—−3.2% | −9.1r−5.5−359%−11.9% | −7.7—−10.6% | −4.2—−6.6% | 3.5—6.0% | −13—−31.1% | |
| Minority interests | — | — | — | — | — | 2.1+16.4%3.1% | 2.2+0.8%2.9% | 1.9—2.6% | 1.5r1.4−25.8%2.0% | 1.8+11.2%2.4% | 2.1—3.4% | 2.1—3.5% | 1.6—3.9% | |
| Total equity | −0.6—−0.9% | −0.6—−0.9% | 3.0r8.0—5.0% | 11r15—15.1% | 18r23—28.8% | −0.9r3.4—−1.3% | −8.4r0.4—−11.4% | −8.5r−0.4—−11.6% | −11r−4.0−360%−14.3% | −5.1r−6.0—−7.0% | −1.9r−2.1—−3.0% | 4.2r5.6—7.2% | −11—−27.2% | |
| Total liabilities and equity | 66—100% | 66+0.5%100% | 60−18.6%100% | 70−4.7%100% | 64r70−16.4%100% | 66−9.1%100% | 74+15.3%100% | 74—100% | 76r72+30.1%100% | 73+78.3%100% | 64—100% | 58—100% | 41—100% | |
| Shares outstanding | 48—— | 48+3.6%— | 48+6.2%— | 48+9.2%— | 47+10.6%— | 47+11.4%— | 45+8.1%— | 44—— | 42+10.3%— | 42+20.6%— | 42—— | 38—— | 35—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 6.6−39.9%3.5% | 1.7*−47.3%3.8% | 0.8*−62.3%1.7% | 1.4−43.1%2.9% | 2.7*−14.5%5.6% | 3.2*+33.6%6.7% | 2.1*—4.3% | 2.5—5.0% | 3.1*−14.8%56.6% | 2.4*−27.4%4.5% | — | 3.6*—8.1% | 3.3—8.5% | |
| Cash from operating activities | −11−185%−5.7% | −0.9*—−2.1% | −6.9*−180%−14.6% | 0.4−85.5%0.9% | −3.3*−406%−7.0% | −0.1*−102%−0.3% | 8.6*—17.6% | 3.1—6.0% | 1.1r1.6*−81.2%19.6% | 6.7r6.2*+522%12.6% | — | 5.7*—12.7% | 1.1*—2.8% | |
| Capital expenditure | −0.5—−0.3% | −0.2*—−0.4% | −0.1*—−0.1% | −0.1—−0.2% | −0.2r−0.2*—−0.4% | −0.8r−0.8*—−1.6% | −0.8r−0.8*—−1.6% | −0.1r−0.1—−0.2% | −0.2r−0.2*—−3.6% | −0.4*—−0.8% | — | −0.1*—−0.2% | −0.0*—−0.1% | |
| Intangible assets bought | — | — | — | — | — | — | — | — | 0*—0.0% | −0.0*—−0.0% | — | 0*—0.0% | 0*—0.0% | |
| Cash from investing activities | 12—6.3% | −1.5*—−3.3% | −1.6*—−3.5% | −2.1—−4.1% | 17*—36.2% | −3.6*—−7.5% | −3.7*—−7.5% | −2.9—−5.6% | −2.7*—−49.6% | −3.5*—−6.6% | — | −2.2*—−4.9% | −2.4*—−6.2% | |
| Debt repaid | — | — | — | — | 0*—0.0% | −17*—−34.9% | — | — | — | — | — | — | — | |
| Shares issued | — | — | — | — | 0*—0.0% | 8.7—18.2% | — | — | — | — | — | — | — | |
| Shares bought back | — | — | — | — | — | −0.3—−0.6% | — | — | — | — | — | — | — | |
| Dividends paid | −3.1—−1.6% | −0.8*—−1.7% | −0.8*—−1.6% | −0.8—−1.5% | −0.8*—−1.6% | −0.8*—−1.6% | −0.8*—−1.6% | −0.8—−1.5% | −0.8*—−14.2% | −0.8*—−1.5% | — | −0.8*—−1.7% | −0.8*—−2.0% | |
| Cash from financing activities | −3.0—−1.6% | −0.8*—−1.7% | −0.8*—−1.6% | −0.7—−1.4% | −0.8*—−1.7% | −8.7*—−18.2% | −3.1*—−6.3% | −0.8—−1.6% | −0.9r−1.4*−107%−17.0% | −1.3r−0.8*−128%−2.5% | — | 14*—32.0% | 4.7*—12.2% | |
| Change in cash | −1.9—−1.0% | −3.2*—−7.2% | −9.3*−609%−19.7% | −2.3—−4.6% | 13*—27.5% | −12*−760%−26.1% | 1.8*—3.7% | −0.6—−1.2% | −2.6*−114%−47.1% | 1.9*−44.3%3.5% | — | 18*—39.8% | 3.4*—8.8% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-K | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What LifeMD, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Business segments
- Telehealth$194 M100%+25%
- Telehealth Subscription Revenue$113 M58%+67%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Executive pay at LifeMD, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Mr. Schreiber | $777 K | $777 K | $1.6 M | $52 |
| 2024Mr. Schreiber | $1.1 M | $1.1 M | $1.1 M | $63 |
| 2023Mr. Schreiber | $889 K | $948 K | $2.1 M | $106 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at LifeMD, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Auditor changed 2 · Acquisition or sale completed 1 · Directors and officers 7 · Material agreement 3 · New debt 2 · Unregistered share sale 2 · Shareholder vote 2 · Results announced 8
| Filed | What happened | Filing |
|---|---|---|
| Material agreementNew debtUnregistered share saleResults announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Acquisition or sale completedMaterial agreement | 8-K | |
| Auditor changed | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Auditor changed | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Unregistered share sale | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026
Acquisitions and funding#
Private share sales · funding history
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at LifeMD, Inc.#
3 labor condition applications certified in fiscal 2026 for 3 positions, at a median wage of $140 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Search Engine Optimization ManagerSearch Marketing Strategists | 2 | $140 K |
| Senior Manager, Financial Planning & AnalysisFinancial Managers | 1 | $165 K |
Where: New York, NY 3
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 3 | 3 | $140 K | 4 |
| FY2025 | 1 | 1 | $140 K | 1 |
| FY2023 | 2 | 2 | $116 K | 3 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as LifeMD, Inc
How LifeMD, Inc. compares in Retail - Pharmacy
- Market cap$112 M · higher than 24% of 35
- Revenue$194 M · higher than 8% of 38
- Net margin-0.2% · higher than 20% of 36
- Revenue growth25.4% · higher than 80% of 11
- Price / sales0.6× · lower than 58% of 25
- Price / book6.1× · lower than 18% of 23
- FCF yield5.7% · higher than 75% of 5
Peer comparison · Retail - Pharmacy
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| LifeMD, Inc.🇺🇸 | $112 M | — | -0.2% | +25.4% |
| Tsuruha Holdings Inc.🇯🇵 | $6.9 B | 23.8× | 2.9% | — |
| Alibaba Health Information Technology Limited🇭🇰 | $6.7 B | 24.0× | 5.7% | — |
| Matsumotokiyoshi Holdings🇯🇵 | $6.2 B | 16.5× | 5.0% | — |
| Yifeng Pharmacy Chain Co., Ltd.🇨🇳 | $4.3 B | 17.8× | 6.9% | — |
| Raia Drogasil S.A.🇧🇷 | $4.1 B | 16.8× | 2.9% | — |
| Selçuk Ecza Deposu Ticaret Ve Sanayi A.S.🇹🇷 | $3.7 B | 72.7× | 3.5% | — |
| Sugi Holdings Co., Ltd.🇯🇵 | $3.3 B | 23.6× | 3.1% | — |
| Cosmos Pharmaceutical Corporation🇯🇵 | $3.3 B | 19.5× | 3.1% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
Sources and freshness
- Market cap:
- Oct 30, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at LifeMD, Inc.? Verify and update this profile — free
Show LifeMD, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.